Scientists constructed adeno-associated viral (AAV) vectors encoding the human variable regions of the SARS-CoV-2 neutralizing antibody, TRES6, fused to murine constant regions. An optimized vector construct was packaged in hepatotropic or myotropic AAV capsids and injected intravenously into syngeneic TRIANNI-mice.
[Communications Biology]